Category: Regulatory and Drug Development Terminology
Orphan Drug Designation
A regulatory designation intended to encourage the development of treatments for rare diseases. In DMD, orphan designation may provide specified development incentives, but it does not mean that a treatment has demonstrated effectiveness or received marketing approval.
- Abbreviation:
- ODD
- Updated November 3, 2026